Vortuzi 100mg Rituximab Injection is a prescription biologic medication used in the treatment of certain blood cancers and autoimmune disorders, including non-Hodgkin lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, and other conditions associated with abnormal B-cell activity. It contains Rituximab, a monoclonal antibody that targets the CD20 protein on B lymphocytes, helping the immune system identify and eliminate these cells. By reducing abnormal or overactive B cells, Vortuzi 100mg Rituximab Injection helps control disease progression and improve treatment outcomes. Administered as an intravenous infusion under the supervision of a healthcare professional, it requires regular monitoring to assess effectiveness and manage potential infusion-related reactions and other side effects. Patients should use Vortuzi 100mg Rituximab Injection only as prescribed by their healthcare provider.

Vortuzi 500mg Rituximab Injection is a prescription biologic medication used in the treatment of certain blood cancers and autoimmune disorders, including non-Hodgkin lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, and other conditions associated with abnormal B-cell activity. It contains Rituximab, a monoclonal antibody that targets the CD20 protein on B lymphocytes, helping the immune system identify and eliminate these cells. By reducing abnormal or overactive B cells, Vortuzi 500mg Rituximab Injection helps control disease progression and improve treatment outcomes. Administered as an intravenous infusion under the supervision of a healthcare professional, it requires regular monitoring to assess treatment effectiveness and manage potential infusion-related reactions and other side effects. Patients should use Vortuzi 500mg Rituximab Injection only as prescribed by their healthcare provider.

X Mab 100mg Rituximab Injection is a prescription biologic medication used in the treatment of certain blood cancers and autoimmune disorders, including non-Hodgkin lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, and other conditions associated with abnormal B-cell activity. It contains Rituximab, a monoclonal antibody that targets the CD20 protein found on B lymphocytes, helping the immune system identify and eliminate these cells. By reducing abnormal or overactive B cells, X Mab 100mg Rituximab Injection helps control disease progression and improve treatment outcomes. Administered as an intravenous infusion under the supervision of a healthcare professional, it requires regular monitoring to assess treatment effectiveness and manage potential infusion-related reactions and other side effects. Patients should use X Mab 100mg Rituximab Injection only as prescribed by their healthcare provider.

X Mab 500mg Rituximab Injection is a prescription biologic medication used in the treatment of certain blood cancers and autoimmune disorders, including non-Hodgkin lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, and other conditions associated with abnormal B-cell activity. It contains Rituximab, a monoclonal antibody that targets the CD20 protein found on B lymphocytes, helping the immune system identify and eliminate these cells. By reducing abnormal or overactive B cells, X Mab 500mg Rituximab Injection helps control disease progression and improve treatment outcomes. Administered as an intravenous infusion under the supervision of a healthcare professional, it requires regular monitoring to assess treatment effectiveness and manage potential infusion-related reactions and other side effects. Patients should use X Mab 500mg Rituximab Injection only as prescribed by their healthcare provider.

We are a leading exporter, supplier, and trader offering Xeloda 500mg Capecitabine Tablets manufactured by Roche Products India Pvt Ltd. These tablets, containing 500mg of Capecitabine, are a potent anticancer medicine for treating colon and rectum cancer. Originating from India, each strip contains 10 tablets, ensuring quality and efficacy. Xeloda tablets are a reliable choice for cancer treatment, providing hope and healing to patients in need. Trust in our commitment to delivering top-notch pharmaceutical products to support cancer patients in their journey towards recovery.

Xpreza 100mg Azacitidine Injection is a prescription anti-cancer medication used in the treatment of myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and certain other bone marrow disorders. It contains Azacitidine, a hypomethylating agent that works by restoring normal gene activity and slowing the growth of abnormal blood cells in the bone marrow. By improving blood cell production, Xpreza 100mg Azacitidine Injection can help reduce transfusion requirements and support better disease management. Administered as a subcutaneous or intravenous injection under the supervision of a healthcare professional, it requires regular monitoring of blood counts and overall health throughout treatment. Patients should use Xpreza 100mg Azacitidine Injection only as prescribed by their healthcare provider and follow all recommended medical appointments.